Drug repurposing for COVID-19 based on an integrative meta-analysis of SARS-CoV-2 induced gene signature in human airway epithelium

Drug repurposing has the potential to bring existing de-risked drugs for effective intervention in an ongoing pandemic—COVID-19 that has infected over 131 million, with 2.8 million people succumbing to the illness globally (as of April 04, 2021). We have used a novel `gene signature’-based drug repo...

Descripción completa

Detalles Bibliográficos
Autores principales: Gupta, Rajaneesh K., Nwachuku, Enyinna L., Zusman, Benjamin E., Jha, Ruchira M., Puccio, Ava M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8478222/
https://www.ncbi.nlm.nih.gov/pubmed/34582497
http://dx.doi.org/10.1371/journal.pone.0257784

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8478222/
https://www.ncbi.nlm.nih.gov/pubmed/34582497
http://dx.doi.org/10.1371/journal.pone.0257784

Ejemplares similares